LGG-30. TRAMETINIB-ASSOCIATED HYPONATREMIA IN A CHILD WITH LOW GRADE GLIOMA IS NOT SEEN FOLLOWING TREATMENT WITH ALTERNATIVE MEK INHIBITOR

Molecularly targeted therapy with MEK inhibitors is increasingly being incorporated into the treatment of pediatric low-grade gliomas (LGGs). Trametinib is an orally available MEK1/2 inhibitor that has demonstrated tumor control in LGGs with BRAF alterations. Safe expansion of MEK inhibitor therapy...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Lazow, Margot A, Lawson, Sarah A, Salloum, Ralph, Hummel, Trent R, Smiley, Natasha Pillay, DeWire-Schottmiller, Mariko D, Fouladi, Maryam, de Blank, Peter M
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2020
主題:
Low Grade Glioma
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715810/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.412
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料